Diversified Healthcare Trust (DHC) is now among the bigger bargains in its industry.
Within the last year the price ranged from $7.06 – 14.32 and there is a wide opportunity to get in. Its next earnings report will be released on Mar 06, 2020.

Corbus Pharmaceuticals Holdings, Inc.(CRBP)

move, based on 2 analysts offering 12 month price targets for Corbus Pharmaceuticals in the last 3 months. The average price target is $23.50 with a high forecast of $24.00 and a low forecast of $23.00. The average price target represents a 229.13% increase from the last price of $7.14.

Analysts like Andrew Fein from H.C. Wainwright believe that we could see stock price minimum $24.00.

Another prominent analyst, Brian Abrahams of RBC Capital rates CRBP as a Buy. The rating was made just 5 days ago.

Corbus Pharmaceuticals Holdings, Inc.(CRBP) Recent News Reports

On average 0.0 articles are written each week about CRBP but this week 0 articles were written and they were 62% Bullish and 38% Bearish.

Corbus Pharmaceuticals Holdings, Inc. Target Levels

The market experts are predicting that CRBP is a Moderate Buy. Some other stocks to consider in this sector are: